Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,500.35
+10.130.41%
Number of Gainers:63
Number of Losers:34
Number of Flat:- -
PE:- -
High:2,507.99
Open:2,490.00
Low:2,489.72
Close:2,490.21
Volume:1.17B
Turnover:249.78B
Market Cap:52.36T
Float Cap:48.98T

Loading ...

Wall Street's Trading Desks Come Down from a Record High

Dow Jones
·
Oct 01

Dow Drops 150 Points on Losses for Shares of Sherwin-Williams Co., Merck

Dow Jones
·
Oct 01

Walmart Stock (WMT) Slips Despite $15M Pledge to Feed Millions of Struggling Americans

TIPRANKS
·
Oct 01

Exchange-Traded Funds Higher, US Equities Mixed After Midday

MT Newswires Live
·
Oct 01

European Stocks Post Worst Monthly Performance Since March as Rate Concerns Intensify

Deep News
·
Oct 01

Sector Update: Healthcare

MT Newswires Live
·
Oct 01

Microsoft Stock (NASDAQ:MSFT) Gains as Copilot Billing to Go Usage-Based by Default in November

TIPRANKS
·
Oct 01

OpenAI: Attribute a Core Cluster of Activity to Individuals Associated with Moonshot AI, the Developer of Kimi - Website

THOMSON REUTERS
·
Oct 01

Analysts’ Top Technology Picks: ASE Technology Holding Co (ASX), Advanced Micro Devices (AMD)

TIPRANKS
·
Oct 01

Nvidia CEO Says AI Could Add 1 Million Jobs in Biggest Industrial Shift in 50 Years

TIPRANKS
·
Oct 01

Open USD launches with over $1B in liquidity commitments

cryptonews
·
Oct 01

Nvidia Buy Rating Reaffirmed as Open Agent Safety Platform and Massive $235B Buyback Underscore AI Leadership; Price Target Maintained at $390

TIPRANKS
·
Oct 01

A Semi Charger Shortage Means a Dip For Tesla Stock (NASDAQ:TSLA)

TIPRANKS
·
Oct 01

Munis, Tips, and More: Best Bonds to Buy Today

Dow Jones
·
Oct 01

Bristol-Myers' Protocol Changes Add Risk, Keep Admilparant on Track, UBS Says

MT Newswires Live
·
Oct 01

‘It’s Too Much,’ Says Investor About Oracle Stock

TIPRANKS
·
Oct 01

BMY Expands Real-World Cancer Data With New AUGTYRO Study in Korea

TIPRANKS
·
Oct 01

Lilly’s Clazakizumab Trial Pushes Cardiovascular Inflammation Strategy Forward

TIPRANKS
·
Oct 01

AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence

TIPRANKS
·
Oct 01

AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline

TIPRANKS
·
Oct 01